NEUROTOXICOLOGY AND TERATOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to advancing knowledge in the critical fields of neuroscience and toxicology. With a focus on the mechanisms of neurotoxic effects and developmental disturbances, this journal serves as a vital resource for researchers, practitioners, and students committed to understanding the complexities of neurotoxicology and its implications for human health. The journal boasts a solid impact factor and holds esteemed quartile rankings, being classified as Q3 in both Cellular and Molecular Neuroscience and Developmental Neuroscience, and Q2 in Toxicology as of 2023. Despite being a subscription-based journal, NEUROTOXICOLOGY AND TERATOLOGY is recognized for its authoritative peer-reviewed articles that encompass a broad spectrum of research from 1987 to 2024, making it indispensable for those who seek in-depth knowledge and current scientific discourse in the field. Its impactful position within Scopus rankings underlines its importance, with notable placement across various neuroscience and toxicology categories.

Journal of Pediatric Neurology, published by GEORG THIEME VERLAG KG, stands as a dedicated resource in the field of pediatric neurology, navigating the complex interplay of neurological and developmental disorders affecting children. With its ISSN 1304-2580 and E-ISSN 1875-9041, this journal has been a pivotal platform for advancing research since its inception in 2003, and continues to present critical findings and discussions up to 2024. Although currently categorized in the Q4 quartile for both Neurology (Clinical) and Pediatrics, Perinatology and Child Health within Scopus rankings, the journal's commitment to fostering scholarly dialogue is essential for researchers, clinicians, and students dealing with pediatric patients. Its structured coverage of various neurological disorders, treatment strategies, and innovative therapies contributes to the broader understanding of pediatric neurology, despite the challenges noted in its ranking percentile. By encouraging submissions from diverse disciplines, the journal aims to enhance clinical practice and bridge gaps in knowledge, ensuring a multidisciplinary approach to child health and development.

Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.

Frontiers in Integrative Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the intricate workings of the nervous system. Since its inception in 2007, this journal has become a key resource for researchers and professionals in the field, covering a wide range of topics including cellular and molecular neuroscience, cognitive neuroscience, and sensory systems. With a reputation bolstered by its open-access model, Frontiers in Integrative Neuroscience aims to promote expedient dissemination of high-quality research, ensuring that all findings are readily accessible to the scientific community and beyond. The journal has achieved a commendable recognition, ranking in the upper tiers of its respective categories according to Scopus, with a Q2 ranking in both cognitive neuroscience and sensory systems, and a Q3 ranking in cellular and molecular neuroscience. Based in Switzerland, it continues to be a pivotal platform for innovative research that shapes our understanding of neural dynamics, encouraging collaboration and knowledge exchange among scholars worldwide.

CLINICAL EEG AND NEUROSCIENCE, published by SAGE Publications Inc, stands as a pivotal journal in the fields of neurology and neuroscience, with a focus on the latest research and advancements in clinical electroencephalography and neurophysiology. Since its inception in 1970, the journal has provided a platform for rigorous scholarly work, offering valuable insights into neurological disorders and EEG technology. With its current categorization in the Q2 and Q3 quartiles across various subfields of medicine and neurology, it ranks prominently in the Scopus database, emphasizing its significance in academic discourse. The journal's commitment to disseminating high-quality research is underscored by its open access options, facilitating broader accessibility to its published findings. For researchers, clinicians, and students alike, CLINICAL EEG AND NEUROSCIENCE remains an essential resource for keeping abreast of the evolving landscape of neurological studies.

Developmental Cognitive Neuroscience is a leading interdisciplinary journal published by ELSEVIER SCI LTD, dedicated to advancing the field of cognitive neuroscience with a specific focus on the developmental aspects of brain function and behavior. Since its inception in 2011, this Open Access journal has continued to thrive, gaining significant recognition with a remarkable impact factor that places it in the Q1 category of cognitive neuroscience, ranking 22nd out of 115 in Scopus. This enhances its visibility and accessibility to a global audience, including researchers, clinicians, and students keen on exploring the intricate relationship between cognitive development and neurological processes. The journal embraces a wide array of topics, from the impact of early life experiences on cognitive outcomes to neurodevelopmental disorders, fostering an enriching platform for disseminating high-quality research and innovative findings. As it progresses towards 2024, Developmental Cognitive Neuroscience remains pivotal in shaping future research and understanding in the field.

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

CORTEX is a premier international journal published by Elsevier Masson, focusing on the cutting-edge areas of cognitive neuroscience, psychology, and neurology. With an impressive impact factor that places it in Q1 quartiles across multiple categories such as Cognitive Neuroscience and Neuropsychology, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 1964, CORTEX has continued to excel in disseminating high-quality scholarly work, offering insights that significantly enhance our understanding of the brain's functioning and behavior. Although not an open-access publication, it provides various access options to ensure the dissemination of knowledge is as wide-reaching as possible. As the field of cognitive psychology evolves, CORTEX remains at the forefront, fostering an environment for interdisciplinary collaboration and innovation. Researchers seeking to stay engaged with the latest advancements will find CORTEX an indispensable tool for their professional development.